Rituxan (rituximab) - Roche
ceftriaxone - Generic mfg.
Type II Cryoglobulinemic Glomerulonephritis Presenting with Near Full-House Immunofluorescence (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #SA-PO0745; Pres time: Oct 24, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Case Description A 75-year-old woman with hypertension and type 2 diabetes mellitus initially presented with cough, hemoptysis and dyspnea and received ceftriaxone for presumed pneumonia...Rituximab was subsequently added after biopsy findings supported cryoglobulinemic glomerulonephritis, resulting in a discharge serum creatinine of 0.9 mg/dL...Negative serum cryoglobulin testing did not exclude the diagnosis. Early biopsy-guided immunosuppressive therapy resulted in dramatic renal recovery and clinical stabilization." 
ANCA Vasculitis • Cardiovascular • Cough • Diabetes • Glomerulonephritis • Hepatology • Hypertension • Immunology • Infectious Disease • Inflammation • Inflammatory Arthritis • Lupus • Lupus Nephritis • Metabolic Disorders • Monoclonal Gammopathy • Nephrology • Optic Neuritis • Pneumonia • Pulmonary Disease • Renal Disease • Respiratory Diseases • Type 2 Diabetes Mellitus • Vasculitis
https://www.asn-online.org/education/kidneyweek/2026/program-abstract.aspx?controlId=4558762
 
Saide Elif Gullulu Boz; Asena Serap Karatutlu; Serdar Kahvecioglu; Ozger Akarsu; Nazife Nur Ozer Sensoy; Nimet Aktas
 
Oct 2, 2026
 
Prev Next